JUST IN: Sanofi gets FDA clearance for heart treatment Multaq - The Food and Drug Administration cleared (FDA) Multaq twice-daily 400 mg tablets to reduce the risk of cardiovascular hospitalisation in …
Today’s Top Three in Pharma 063009
Ouch. Jury returns $ 1.67 billion verdict against Abbott (patent infringement vs J&J) - A U.S. federal jury returned a $1.67 billion verdict against Abbott Laboratories in a patent suit brought by …
Today’s Top Three in Pharma 062909
I think it's going to be more than 3 today...! Does Lantus (Sanofi drug for diabetes) increase cancer risk? Takeda's alogliptin (new diabetes treatment) - FDA says, more info please. European …
Today’s Top Three in Pharma 061809
Medtronic, a doctor, transparency, and 800K - Remember that former Army doctor accused of faking data in a published study that found positive results for a Medtronic product? Turns out, Medtronic …
Today’s Top Three in Pharma 043009
Ortho-McNeil launches Facebook page for adult ADHD sufferers. Lilly and Amylin teaming up to produce once-a-week diabetes pen. Good stuff on Merck KGaA's oral MS drug. That company and Novartis both …
Today’s Top Three in Pharma 042909
"Physicians and medical institutions should shun gifts, reps, samples and ghostwriting, said the Institute of Medicine's conflict of interest committee in its full recommendations." More... Who needs …